| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |